<!DOCTYPE html>
                <html>
                <head>
                    <title>AI in Pharmacy: Speeding up Drug Discovery</title>
                <?php include_once 'Elemental/header.php'; ?><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><br><br><h5> This article is reformatted from originally published at <a href="https://medium.com/sciforce/ai-in-pharmacy-speeding-up-drug-discovery-c7ca252c51bc"><strong>TDS(Towards Data Science)</strong></a></h5></br><h5> <a href="https://medium.com/@sciforce?source=post_page-----c7ca252c51bc--------------------------------">Author : Sciforce</a> </h5></div></div></div></section><section data-bs-version="5.1" class="content4 cid-tt5SM2WLsM" id="content4-2" style="padding-top:0px; padding-bottom:0px; background-color: rgb(255, 255, 255);">
            <div class="container">
                <div class="row justify-content-center">
                    <div class="title col-md-12 col-lg-9">
                        <h3 class="mbr-section-title mbr-fonts-style mb-4 display-2">
                            <strong>AI in Pharmacy: Speeding up Drug Discovery</h3></div></div></div></section><section data-bs-version="5.1" class="image3 cid-tt612oXwA9" id="image3-5" style="padding-top:0px; padding-bottom:0px; background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-12 col-lg-9">
                <div class="image-wrapper"><div class="image_style" style="width:96%;"><picture><source sizes="(min-resolution: 4dppx) and (max-width: 700px) 50vw, (-webkit-min-device-pixel-ratio: 4) and (max-width: 700px) 50vw, (min-resolution: 3dppx) and (max-width: 700px) 67vw, (-webkit-min-device-pixel-ratio: 3) and (max-width: 700px) 65vw, (min-resolution: 2.5dppx) and (max-width: 700px) 80vw, (-webkit-min-device-pixel-ratio: 2.5) and (max-width: 700px) 80vw, (min-resolution: 2dppx) and (max-width: 700px) 100vw, (-webkit-min-device-pixel-ratio: 2) and (max-width: 700px) 100vw, 700px" srcset="https://miro.medium.com/v2/resize:fit:640/0*OoBQ8ZPmSCSzWyyD 640w, https://miro.medium.com/v2/resize:fit:720/0*OoBQ8ZPmSCSzWyyD 720w, https://miro.medium.com/v2/resize:fit:750/0*OoBQ8ZPmSCSzWyyD 750w, https://miro.medium.com/v2/resize:fit:786/0*OoBQ8ZPmSCSzWyyD 786w, https://miro.medium.com/v2/resize:fit:828/0*OoBQ8ZPmSCSzWyyD 828w, https://miro.medium.com/v2/resize:fit:1100/0*OoBQ8ZPmSCSzWyyD 1100w, https://miro.medium.com/v2/resize:fit:1400/0*OoBQ8ZPmSCSzWyyD 1400w" type="image/webp"/><source data-testid="og" sizes="(min-resolution: 4dppx) and (max-width: 700px) 50vw, (-webkit-min-device-pixel-ratio: 4) and (max-width: 700px) 50vw, (min-resolution: 3dppx) and (max-width: 700px) 67vw, (-webkit-min-device-pixel-ratio: 3) and (max-width: 700px) 65vw, (min-resolution: 2.5dppx) and (max-width: 700px) 80vw, (-webkit-min-device-pixel-ratio: 2.5) and (max-width: 700px) 80vw, (min-resolution: 2dppx) and (max-width: 700px) 100vw, (-webkit-min-device-pixel-ratio: 2) and (max-width: 700px) 100vw, 700px" srcset="https://miro.medium.com/v2/resize:fit:640/0*OoBQ8ZPmSCSzWyyD 640w, https://miro.medium.com/v2/resize:fit:720/0*OoBQ8ZPmSCSzWyyD 720w, https://miro.medium.com/v2/resize:fit:750/0*OoBQ8ZPmSCSzWyyD 750w, https://miro.medium.com/v2/resize:fit:786/0*OoBQ8ZPmSCSzWyyD 786w, https://miro.medium.com/v2/resize:fit:828/0*OoBQ8ZPmSCSzWyyD 828w, https://miro.medium.com/v2/resize:fit:1100/0*OoBQ8ZPmSCSzWyyD 1100w, https://miro.medium.com/v2/resize:fit:1400/0*OoBQ8ZPmSCSzWyyD 1400w"/><img alt="" loading="lazy" role="presentation" src="https://miro.medium.com/max/700/0*OoBQ8ZPmSCSzWyyD"></picture></div><br></div></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">We are already accustomed that a part of work in healthcare can be done by machines. They have proved to be effective in helping with diagnostics or treatment line selection, as well as with the document flow management. Yet, once we cast a glance beyond patient-healthcare providers relations, we are amazed at the scale of the problems and the potential for AI to solve them.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">$ 2.5b and 10 years of research — these are the figures that describe the drug development process. Add up to them that only 1 in 10 drug would pass all necessary stages and eventually reach the patient. The present-day fast and furious world can afford neither such expenses nor such time frame.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">It is here that AI techniques can add the most value, making the drug discovery quicker, cheaper and more effective. Some pharmacists are still skeptical, but most experts expect these tools to become increasingly important. If the proponents of these techniques are right, AI and machine learning will usher in an era of quicker, cheaper and more-effective drug discovery</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">For instance,<a href="https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/how-big-data-can-revolutionize-pharmaceutical-r-and-d" target="_self"> McKinsey estimates</a> that better decision-making, optimized innovation, improved efficiency of research, clinical trials, and new tool creation with the help of big data and machine learning could generate up to $100b in pharma and medicine annually.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">AI has the potential to change the whole process of drug discovery. So far, the stages of drug development starting from a hypothesis and going toward testing the drugs are not connected at all. On the contrary, from a machine learning perspective, the stages become interconnected since you can use the data from the next stage to understand what happens in the previous stage or two stages before.<strong> </strong>Besides, the simultaneous access to multiple data can identify a quantifiable segment instead of using broad descriptors, such as disease symptoms. With machine learning, researchers can perform a trial on a pool of patients, receive different results and map them onto the patients’ genetics of molecular signatures, defining disease on a firmer ground.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">AI has already been used successfully in all main stages in drug development:</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· Stage 0. Literature overview</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· Stage 1: Identifying targets for intervention</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· Stage 2: Discovering drug candidates</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· Stage 3: Speeding up clinical trials</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· Stage 4: Finding Biomarkers for diagnosing the disease</p></div></div></div></section><section data-bs-version="5.1" class="image3 cid-tt612oXwA9" id="image3-5" style="padding-top:0px; padding-bottom:0px; background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-12 col-lg-9">
                <div class="image-wrapper"><div class="image_style" style="width:96%;"><picture><source sizes="(min-resolution: 4dppx) and (max-width: 700px) 50vw, (-webkit-min-device-pixel-ratio: 4) and (max-width: 700px) 50vw, (min-resolution: 3dppx) and (max-width: 700px) 67vw, (-webkit-min-device-pixel-ratio: 3) and (max-width: 700px) 65vw, (min-resolution: 2.5dppx) and (max-width: 700px) 80vw, (-webkit-min-device-pixel-ratio: 2.5) and (max-width: 700px) 80vw, (min-resolution: 2dppx) and (max-width: 700px) 100vw, (-webkit-min-device-pixel-ratio: 2) and (max-width: 700px) 100vw, 700px" srcset="https://miro.medium.com/v2/resize:fit:640/0*3IwMk8mNVvEpqh6- 640w, https://miro.medium.com/v2/resize:fit:720/0*3IwMk8mNVvEpqh6- 720w, https://miro.medium.com/v2/resize:fit:750/0*3IwMk8mNVvEpqh6- 750w, https://miro.medium.com/v2/resize:fit:786/0*3IwMk8mNVvEpqh6- 786w, https://miro.medium.com/v2/resize:fit:828/0*3IwMk8mNVvEpqh6- 828w, https://miro.medium.com/v2/resize:fit:1100/0*3IwMk8mNVvEpqh6- 1100w, https://miro.medium.com/v2/resize:fit:1400/0*3IwMk8mNVvEpqh6- 1400w" type="image/webp"/><source data-testid="og" sizes="(min-resolution: 4dppx) and (max-width: 700px) 50vw, (-webkit-min-device-pixel-ratio: 4) and (max-width: 700px) 50vw, (min-resolution: 3dppx) and (max-width: 700px) 67vw, (-webkit-min-device-pixel-ratio: 3) and (max-width: 700px) 65vw, (min-resolution: 2.5dppx) and (max-width: 700px) 80vw, (-webkit-min-device-pixel-ratio: 2.5) and (max-width: 700px) 80vw, (min-resolution: 2dppx) and (max-width: 700px) 100vw, (-webkit-min-device-pixel-ratio: 2) and (max-width: 700px) 100vw, 700px" srcset="https://miro.medium.com/v2/resize:fit:640/0*3IwMk8mNVvEpqh6- 640w, https://miro.medium.com/v2/resize:fit:720/0*3IwMk8mNVvEpqh6- 720w, https://miro.medium.com/v2/resize:fit:750/0*3IwMk8mNVvEpqh6- 750w, https://miro.medium.com/v2/resize:fit:786/0*3IwMk8mNVvEpqh6- 786w, https://miro.medium.com/v2/resize:fit:828/0*3IwMk8mNVvEpqh6- 828w, https://miro.medium.com/v2/resize:fit:1100/0*3IwMk8mNVvEpqh6- 1100w, https://miro.medium.com/v2/resize:fit:1400/0*3IwMk8mNVvEpqh6- 1400w"/><img alt="" loading="lazy" role="presentation" src="https://miro.medium.com/max/700/0*3IwMk8mNVvEpqh6-"></picture></div><p class="mbr-description mbr-fonts-style mt-2 align-center display-12 text-muted" style="font-size:12px;">Main stages in drug development</p><br></div></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;"><strong>Stage 0 Literature overview</strong></p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">There is an enormous amount of research that gets published every day and if we could collate the insights from all studies, we can formulate a better hypothesis. However, it is impossible for a human to read all abstracts and scientific papers, so researchers that work in the scientific domain usually just focus on one area and do not read other journals. But these journals contain a lot of relevant data that can inform decisions in the areas that a person is researching on. The solution is to let machines read all available literature, patents, and documents and pool the data together in a database of facts that can be extracted from this literature. That forms the basis of the hypothesis to find therapeutic targets for diseases.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;"><strong>Stage 1: Identification of targets for intervention</strong></p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">The first step in drug development is to understand the biological origin of a disease and its resistance mechanisms. To treat a disease, it is crucial to identify good targets, usually, proteins. The broad application of high-throughput techniques, such as short hairpin RNA (shRNA) screening and deep sequencing, has boosted the amount of data available for discovering viable target pathways. However, it’s still a challenge to integrate the high number and variety of data sources — and then find the relevant patterns. Machine learning algorithms are known to be good in such tasks and can handle all available data to automatically predict good target proteins.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;"><strong>Stage 2: Drug candidates discovery</strong></p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">With targets identified, researchers start looking for a compound that can interact with the identified target molecule in the desired way. This involves screening thousands and millions of potential natural, synthetic and bioengineered compounds for their effect on the target and their side-effects. Machine Learning algorithms can predict the suitability of a molecule based on structural fingerprints and molecular descriptors, blaze through millions of potential molecules and filter them down to the best options with minimal side effects.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;"><strong>Stage 3: Faster clinical trials</strong></p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">The key to successful trials is an accurate selection of suitable candidates, because choosing wrong entails prolongation of trials and waste of time and resources. Machine Learning can speed up the design of clinical trials by automatically identifying suitable candidates and ensuring that the trial participants are distributed among groups correctly. ML algorithms can identify patterns that would predict good candidates. Besides, they can notify the researchers that a clinical trial is not producing conclusive results so that the researchers could intervene earlier, and potentially save the development of the drug.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;"><strong>Stage 4: Identification of biomarkers for diagnosing the disease</strong></p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">Finally, you can only treat patients for a disease once you’re sure of your diagnosis. Biomarkers are molecules found in bodily fluids such as blood that <strong>provide absolute certainty as to whether or not a patient has a disease</strong>. They make the process of diagnosing a disease <strong>secure and cheap</strong>. They can be also used to pinpoint the progression of the disease — making it easier for doctors to choose the correct treatment and monitor whether the drug is working.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">Yet, discovering biomarkers involves screening tens of thousands of potential molecule candidates. Once again, AI can automate and speed up the process. The algorithms classify molecules into good and bad candidates — and researcher can focus on analyzing only the best prospects.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;"><strong>Biomarkers can identify:</strong></p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· <em>Diagnostic biomarker:</em> The presence of a disease as early as possible</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· <em>Risk biomarker:</em> The risk of a patient developing the disease</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· <em>Prognostic biomarker:</em> The likely progress of a disease</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">· <em>Predictive biomarker:</em> Whether a patient will respond to a drug</p></div></div></div></section><section data-bs-version="5.1" class="image3 cid-tt612oXwA9" id="image3-5" style="padding-top:0px; padding-bottom:0px; background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-12 col-lg-9">
                <div class="image-wrapper"><div class="image_style" style="width:96%;"><picture><source sizes="(min-resolution: 4dppx) and (max-width: 700px) 50vw, (-webkit-min-device-pixel-ratio: 4) and (max-width: 700px) 50vw, (min-resolution: 3dppx) and (max-width: 700px) 67vw, (-webkit-min-device-pixel-ratio: 3) and (max-width: 700px) 65vw, (min-resolution: 2.5dppx) and (max-width: 700px) 80vw, (-webkit-min-device-pixel-ratio: 2.5) and (max-width: 700px) 80vw, (min-resolution: 2dppx) and (max-width: 700px) 100vw, (-webkit-min-device-pixel-ratio: 2) and (max-width: 700px) 100vw, 700px" srcset="https://miro.medium.com/v2/resize:fit:640/0*TmrhJUPK-KwVNmY_ 640w, https://miro.medium.com/v2/resize:fit:720/0*TmrhJUPK-KwVNmY_ 720w, https://miro.medium.com/v2/resize:fit:750/0*TmrhJUPK-KwVNmY_ 750w, https://miro.medium.com/v2/resize:fit:786/0*TmrhJUPK-KwVNmY_ 786w, https://miro.medium.com/v2/resize:fit:828/0*TmrhJUPK-KwVNmY_ 828w, https://miro.medium.com/v2/resize:fit:1100/0*TmrhJUPK-KwVNmY_ 1100w, https://miro.medium.com/v2/resize:fit:1400/0*TmrhJUPK-KwVNmY_ 1400w" type="image/webp"/><source data-testid="og" sizes="(min-resolution: 4dppx) and (max-width: 700px) 50vw, (-webkit-min-device-pixel-ratio: 4) and (max-width: 700px) 50vw, (min-resolution: 3dppx) and (max-width: 700px) 67vw, (-webkit-min-device-pixel-ratio: 3) and (max-width: 700px) 65vw, (min-resolution: 2.5dppx) and (max-width: 700px) 80vw, (-webkit-min-device-pixel-ratio: 2.5) and (max-width: 700px) 80vw, (min-resolution: 2dppx) and (max-width: 700px) 100vw, (-webkit-min-device-pixel-ratio: 2) and (max-width: 700px) 100vw, 700px" srcset="https://miro.medium.com/v2/resize:fit:640/0*TmrhJUPK-KwVNmY_ 640w, https://miro.medium.com/v2/resize:fit:720/0*TmrhJUPK-KwVNmY_ 720w, https://miro.medium.com/v2/resize:fit:750/0*TmrhJUPK-KwVNmY_ 750w, https://miro.medium.com/v2/resize:fit:786/0*TmrhJUPK-KwVNmY_ 786w, https://miro.medium.com/v2/resize:fit:828/0*TmrhJUPK-KwVNmY_ 828w, https://miro.medium.com/v2/resize:fit:1100/0*TmrhJUPK-KwVNmY_ 1100w, https://miro.medium.com/v2/resize:fit:1400/0*TmrhJUPK-KwVNmY_ 1400w"/><img alt="" loading="lazy" role="presentation" src="https://miro.medium.com/max/700/0*TmrhJUPK-KwVNmY_"></picture></div><p class="mbr-description mbr-fonts-style mt-2 align-center display-12 text-muted" style="font-size:12px;">Types of biomarkers</p><br></div></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">Even though broad application of AI is still in its infantry, there are multiple examples of its use by pharmaceutical companies. For example, the pharmaceutical giant Merck & Co is working on a project which uses deep learning technology for the discovery of novel small molecules. Pfizer has started a collaboration with IBM Watson for immuno-oncology drug discovery research. Researchers at the Massachusetts-based biotechnology company Berg have developed a model to identify previously unknown cancer mechanisms using tests on more than 1,000 cancerous and healthy human cell samples.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">This shift presents suggests the industry has not only woken up to but is actively embracing the benefits of machine learning to identify and screen drugs, more accurately predict drug candidates and, ultimately, cut R&D costs and effort.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-10">
            <br>
                <hr class="hr5">
            <br>
            </div>
        </div>
    </div>
</section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><h4 class="mbr-section-subtitle mbr-fonts-style mb-4 display-5">How will AI change the future of human experts?</h4></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">As more studies are published and discussions are held around the future of AI in medicine, distinct sides to the argument emerge. The general consensus is that while routine tasks and data collection/entry should be done by machines, there will always be a need for the human element of the curator’s role, in judgment, creativity, and empathy or other human factors that modern technology cannot provide.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">As curators, humans will set up the problem and let the algorithms or robots solve it. They will tailor and target specific compounds, symptoms, diseases or others rather than random or minute problems just for the sake of doing so. Besides, human experts will provide approval through the different phases of testing or exploring further options based on results based on context that the bots may not understand.</p></div></div></div></section><section data-bs-version="5.1" class="content5 cid-tt5UseJ9wk" id="content5-4" style="padding-top:0px; padding-bottom:0px;background-color: rgb(255, 255, 255);">
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-9"><p class="ff3" style="font-size:22px;">In conclusion, the future lies in cooperation between humans and machines and human clinical experts will have to adapt, learn and grow alongside technological advancements. Though future specialists will need to be both medical and computer experts, for medicine, it is evolution, not extinction.</p></div></div></div></section><?php include_once 'Elemental/footer.php'; ?>